Senate Showdown: CLARITY Act's Future Hangs by a Thread, Galaxy Research Warns

Galaxy Digital’s research arm has significantly reduced its projection for the CLARITY Act becoming law in 2026, downgrading the odds to 50-50 from 60% just three weeks prior. This revised estimate, articulated by Galaxy researcher Alex Thorn, is primarily driven by a rapidly shortening Senate floor calendar and the bill's persistent lack of a merged text, a scheduled vote, or a public commitment from Senate leadership.

The CLARITY Act, formally known as the Digital Asset Market Structure and Investor Protection Act, represents a landmark effort by the U.S. Congress to establish a comprehensive regulatory framework for digital assets. It seeks to delineate jurisdictional boundaries between the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC), define standards for classifying digital assets as either commodities or securities, and incorporate the Blockchain Regulatory Certainty Act (BRCA), which offers protections for certain blockchain developers and node operators. The bill achieved a notable bipartisan passage from the Senate Banking Committee on May 14 with a 15-9 vote and has since been listed as item No. 423 on the Senate Legislative Calendar, awaiting further action. Despite this initial progress, no floor date or motion to proceed has been scheduled.

The primary hurdle for the CLARITY Act is its calendar problem, exacerbated by the fact it is a 60-vote bill, requiring significant bipartisan support to overcome a potential filibuster. With the Senate slated to commence its August recess by the end of July, a tight window remains. Before any floor vote can realistically occur, a unified legislative text, reconciling versions from the Banking and Agriculture committees, must be finalized and publicly released. Subsequently, a motion to proceed needs to be filed, followed by floor debate and an amendment process. Even if these steps are completed, the House of Representatives would then need to act on the Senate’s output. Thorn's analysis suggests that for a July vote to be feasible, Senate Majority Leader John Thune would need to announce floor time by early July “at the latest.” Failure to do so would push the timeline to September, where the bill would confront the complexities of midterm-election dynamics, making controversial votes exceptionally difficult to schedule.

Compounding the CLARITY Act’s scheduling woes is an intensifying competition for limited floor time. Congress is grappling with several other critical legislative priorities. Section 702 of the Foreign Intelligence Surveillance Act (FISA) lapsed on June 12 after a reauthorization bill failed to pass, and a new proposal from Senators Grassley, Cotton, and Warner still requires floor consideration. The FY2027 National Defense Authorization Act (NDAA), a perennial must-pass defense bill, also remains unfinished. Furthermore, President Trump's recent cancellation of a scheduled signing for a bipartisan housing bill, conditioning his signature on the passage of the SAVE Act—a proof-of-citizenship elections bill that Thune indicates lacks the votes to pass the chamber—injects another high-stakes, leadership-consuming legislative battle into an already crowded agenda.

Beyond the calendar, substantive issues also remain unresolved. The ethics question stands as a central open concern; a Van Hollen conflict-of-interest amendment failed in committee by an 11-13 vote, and Senators Ruben Gallego and Cory Booker continue to demand enforceable ethics standards as a prerequisite for their support. Additionally, at least two Republican senators, Josh Hawley and Rand Paul, are anticipated to vote against the bill, underscoring the indispensable need for Democratic crossover support. Law enforcement-aligned senators are also advocating for further modifications to the developer-protection language embedded within the BRCA.

Galaxy’s research identifies specific conditions that could improve the bill's prospects: a public agreement on a combined Banking-Agriculture text, a credible resolution of the ethics or BRCA disputes that solidifies a durable Democratic bloc of support, and a firm floor commitment from leadership for a July vote. Thorn emphasized that a scheduling announcement within the next two weeks would elevate the firm’s estimate back to 60% or higher, whereas continued silence into mid-July would further diminish the bill’s chances. For now, the CLARITY Act remains at No. 423 on the Senate calendar—a tangible, yet unscheduled, piece of legislation in a chamber consistently occupied with other pressing matters.